Background and purpose: The aim was to assess the feasibility and safety of fast-track hospitalizations in a selected cohort of patients with stroke. Methods: Patients hospitalized at the Stroke Center of the University Hospital Basel, Switzerland, with an acute ischaemic stroke confirmed on magnetic resonance diffusion-weighted imaging were included. Neurological deficits of the included patients were non-disabling, i.e. not interfering with activities of daily living and compatible with a direct discharge home. Patients with premorbid disability were excluded. All patients were admitted to the Stroke Center for ≥24 h. Two study groups were compared -fast-track hospitalizations (≤72 h) and long-term hospitalizations (>72 h). The primary end-point was a composite of any unplanned rehospitalization for any reason within 3 months since hospital discharge and a modified Rankin Scale 3-6 at 3 months. Adjustment for confounders was done using the inverse probability of treatment weights (IPTW). Results: Amongst the 521 patients who met the inclusion criteria, fast-track hospitalizations were performed in 79 patients (15%). In the fast-track group, seven patients (8.9%) met the primary end-point, compared to 37 (8.4%) in the long-term group [odds ratio (OR) 1.06, 95% confidence interval (CI) 0.42-2.34, P = 0.88]. After weighting for IPTW, the odds of the primary end-point remained similar between the two arms (OR IPTW 1.27, 95% CI 0.51-3.16, P = 0.61). The costs of fast-track hospitalizations were lower, on average, by $4994. Conclusions: Fast-track hospitalizations including a full workup proved to be feasible, showed no increased risk and were less expensive than long-term hospitalizations.
Introduction
Compared to regular wards, stroke units are associated with improved functional outcome and lower mortality, as reflected by an odds reduction by 20 percentage points in the composite of death and dependency at a median follow-up of 1 year, as shown by randomized controlled trials [1] and observational studies [2] [3] [4] [5] [6] [7] [8] [9] . Direct admission to a hospital with a stroke unit was associated with shorter intervals between stroke onset and start of intravenous thrombolysis [10] . The mean length of stay (LOS) in acute hospitals with a stroke unit varies considerably across studies, ranging from 11 to 21 days in a meta-analysis of 28 trials including 5855 patients published in 2013 [1] . Over the past decade, many advances in the treatment of acute ischaemic stroke (AIS) took place, potentially affecting LOS. For instance, thrombectomy for large-vessel occlusion led to neurological recovery at 24 h in 50.2% of patients in the five pivotal randomized trials published in 2015 comparing thrombectomy to standard treatment [11] . These advances, along with the pressure to contain healthcare expenditures, may decrease LOS in the near future. Fast-track hospitalizations with a complete workup may allow patients with stroke to be quickly reintegrated into everyday life whilst reducing hospitalization costs. However, the feasibility, frequency and safety of fast-track hospitalizations are unknown. In this cohort study, the aim was to compare fasttrack hospitalizations to long-term hospitalizations amongst patients hospitalized with an AIS whose neurological deficits at discharge were non-disabling, i.e. compatible with a discharge home.
Methods Ethics statement
The study was approved by the Institutional Review Board of Northwestern and Central Switzerland (Project-ID 2017-00213). According to the Swiss Federal Law on Human Research, all patients or their relatives were informed of the analysis of their coded data (non-genetic and non-biological) for research purposes. They had the right to object to the use of their data. Signed informed consent was not necessary.
Study design and decision on type of hospitalization
This is a retrospective cohort study, culled from the Swiss Stroke Registry (SSR). In this analysis of our local SSR data, two arms were compared: (i) fasttrack hospitalizations, defined as hospitalization with discharge up to 72 h after admission to the University Hospital Basel; (ii) long-term hospitalizations, i.e. when discharge occurred >72 h after admission to the University Hospital Basel.
The decision on the timing of discharge home -and thus on the hospitalization type -was taken by a multidisciplinary team including the attending physician, therapists and nurses on a patient-by-patient basis.
Inclusion and exclusion criteria
Inclusion criteria were as follows: (i) AIS, defined as acute focal neurological deficit with a corresponding lesion on magnetic resonance (MR) diffusion-weighted imaging; (ii) non-disabling neurological deficits, defined as not interfering with activities of daily living and compatible with a direct discharge home without help from a third party; patients with disabling neurological deficits upon hospital admission could be included if the neurological deficits improved during the hospitalization and were non-disabling at discharge; (iii) hospitalization at the Basel University Hospital Stroke Center between 1 January 2014 and 31 December 2015; (iv) older than 18 years.
Exclusion criteria were as follows: (i) transient ischaemic attack (TIA), defined as an acute focal neurological deficit without a lesion on MR diffusionweighted imaging (tissue-based definition); (ii) premorbid dependency, defined as modified Rankin Scale (mRS) 3-5 or living in a care facility prior to the index stroke; (iii) need of further in-hospital rehabilitation in a rehabilitation facility after the index stroke; (iv) transfer to a care facility or hospice; (v) in-hospital death.
Patients were included independently of the stroke severity on admission, assessed by the National Institutes of Health Stroke Scale (NIHSS). As per internal standard operating procedure, all patients with AIS were admitted to the Stroke Center for at least 24 h and were assessed at least once by a physiotherapist, a speech therapist and an occupational therapist.
Workup and recurrence prophylaxis
Diagnostic workup included brain MR imaging (MRI), imaging of the cervical and intracranial arteries (by either angio-computed tomography, angio-MRI or ultrasound), echocardiography, and at least 24 h of cardiac rhythm monitoring unless atrial fibrillation was previously known. A complete in-hospital workup was attempted in all patients, and the rate of complete in-hospital workups was assessed. Recurrence prophylaxis consisted of control of modifiable cardiovascular risk factors, antiplatelet drugs or, if atrial fibrillation was known or detected, oral anticoagulation unless contraindicated. Carotid endarterectomy or stenting for symptomatic stenosis was performed during the same index hospitalization.
Costs of index hospitalizations
Costs of index hospitalizations were standardized based on diagnosis-related groupings according to a uniform nationwide system (SwissDRG). Professional coders from the Medical and Finance Controlling Division of the University Hospital Basel translated the discharge reports into an alphanumeric SwissDRG code to compile the healthcare insurance claim, from which the costs of the index hospitalization were extracted. Since Switzerland has a universal healthcare system, it was possible to extract the costs of each index hospitalization.
End-points
The primary end-point was a composite of unplanned rehospitalization for any reason within 3 months since hospital discharge and an mRS of 3-6 at 3 months. An unplanned rehospitalization was defined as occurring via the emergency department. The secondary end-points were as follows: (i) the composite of any unplanned rehospitalization at 1 month or mRS 3-6 at 3 months; (ii) the time to any unplanned rehospitalization within 1 month; (iii) the time to any unplanned rehospitalization within 3 months.
Follow-up
To assess the 3-month end-points, trained personnel performed in-person visits (for patients treated with recanalization therapy) or telephone calls. Occurrence, duration and costs of rehospitalizations were verified through the Medical and Finance Controlling Division of the University Hospital Basel.
Statistics
Patients' demographics and presentations are summarized using the median alongside the first and third quartile of the distribution for continuous variables (interquartile range, IQR) and the frequency and percentage for categorical variables. Analyses were based on logistic regression models with the relevant outcome as the dependent variable and the classification of fast-track or long-term as the predictor. Two different methods were used to examine the effect of potential confounding factors. First, based on propensity scores (PSs), the analysis was repeated whilst weighting patients by their inverse probability of treatment weights (IPTW). This allowed unbiased estimates of the average treatment effect to be calculated, accounting for potential confounders. Here, the PS is the probability of a patient being discharged via fast-track rather than long-term as calculated conditionally on selected baseline variables. The analysis was repeated using another method to account for potential confounding, namely PS stratification, in which patients were divided into five strata based on their PS. A conditional logistic regression model was then fitted, stratified by PS strata.
As confounders and predictors in the PS model, it was decided to include patient age, NIHSS on admission, performance of recanalization therapy (binary), diabetes and comorbidities. Comorbidities were calculated using the patient clinical complexity level (PCCL) score, i.e. a calculated index of disease burden per patient based on the amount and constellation of secondary diagnoses. PCCL ranges from 0 to 4 (only integer values), with 0 indicating the absence of comorbidities and 4 very severe comorbidities [12] .
To analyze time to unplanned rehospitalization, Cox proportional hazards models and Kaplan-Meier curves were used to assess the cumulative incidence of events. Patients were censored at 3 months post-index event or at time of planned hospitalization if taking place. The analysis was repeated for a time period of 1 month. As with the primary analysis, control for confounding was performed once by weighting models by IPTW and by stratification on PS strata.
The costs of index hospitalizations were compared between fast-track and long-term using non-parametric Kruskal-Wallis tests. To examine confounding, costs too were repeated using IPTW; to incorporate PS stratification for index costs, a linear mixed-effects model was used on log-transformed index costs, with PS strata included as a random effect. Two-sided P values <0.05 were considered significant. All analyses were performed using R version 3.4.0 (R Core Team, 2017).
Results
Between 1 January 2014 and 31 December 2015, 521 patients were enrolled. Fast-track hospitalizations were performed for 79 patients (15%), long-term hospitalizations for 442 patients (85%). In the fast-track group, the average LOS was 3 days (IQR 2-3), compared to 7 days (IQR 5-10) in the long-term group (P < 0.001). Table 1 summarizes the baseline characteristics. The diagnostic workup was complete for 73 patients (92%) in the fast-track group and for 430 patients (97%) in the long-term group (P = 0.04) ( Table 1) . Atrial fibrillation was detected in 13 patients in the fast-track arm (16%) and in 62 patients in the long-term arm (14%, P = 0.60). Oral anticoagulation was prescribed in all patients with atrial fibrillation in the fast-track arm (100%) and in 55 patients in the long-term arm (89%). All other patients received a platelet inhibitor. A carotid endarterectomy or stenting was performed in no patient of the fasttrack group and in 31 patients of the long-term arm (7%). As per our standard operating procedure, all patients were assessed at least once by a speech therapist, physiotherapist and ergo-therapist on the first day of hospitalization, independent of the prospected hospitalization length.
Information on the primary end-point was available for all 521 patients. In the fast-track group, seven patients (8.9%) met the primary end-point, compared to 37 (8.4%) in the long-term group (unadjusted OR 1.06, 95% CI 0.42-2.34, P = 0.88). No patient in both groups died within 3 months of index hospital discharge. After adjusting for age, NIHSS, diabetes, comorbidities and performance of recanalization therapy, the odds of the primary end-point remained similar between both arms (OR IPTW 1.27, 95% CI 0.51-3.16, P = 0.61) ( Table 2 ). Excluding patients with planned rehospitalizations (n = 39) did not alter the estimated ORs for unfavorable outcome at 3 months, neither in the unadjusted analysis (OR 1.05, 95% CI 0.42-2.32, P = 0.91) nor in the adjusted analysis (OR IPTW 1.27, 95% CI 0.50-3.18, P = 0.62). Patients with lower probabilities of being in the fasttrack group (lower PS) tended to have higher odds of the primary end-point, i.e. of having an unfavorable outcome (Table 3) .
For none of the secondary end-points was a significant difference observed between the fast-track and long-term groups (Tables 4 and 5 ). Figure 1 shows that the Kaplan-Meier curves for unplanned rehospitalizations are almost overlapping between the two groups. The unadjusted and IPTW-adjusted hazard ratios for unplanned rehospitalization at 3 months were 1.08 (95% CI 0.48-2.42, P = 0.86) and 1.26 (95% CI 0.54-2.95, P = 0.60), respectively.
The costs of the index hospitalizations per patient were lower in the fast-track [$7303 (95% CI $5806-$8681)] compared to the long-term group [$12 297 (95% CI $10 088-$16 866), P < 0.001]. The absolute difference in median costs was $4994, the relative difference À41%.
Discussion
In this cohort of patients hospitalized in our Stroke Center with AIS, fast-track hospitalizations with a complete workup were feasible without increasing the risk of unplanned rehospitalization or poor functional outcome at 3 months. The costs per index hospitalization were, on average, $4994 or À41 percentage points lower in the fast-track compared to the long-term group.
Short LOS has been observed in services providing early supported discharge (ESD). With ESD, average LOS was shorter by 5.5 days, as shown by a Cochrane meta-analysis on 17 clinical trials with 2433 stroke patients. However, even in the ESD arms, the shortest mean LOS was 9.7 days in a trial published 17 years earlier, contrasting with the current trend of decreasing LOS [13, 14] . Moreover, not all hospitalized stroke patients need ESD services, and many hospitals -even in developed countries -do not provide ESD. The average LOS of patients with AIS in Switzerland and abroad is 8 days [1] .
The rate of 8.9% for unplanned rehospitalization or mRS 3-6 observed in the fast-track arm in our study is in stark contrast with the published rate of 27% for rehospitalization and 40% mRS 3-6 after discharge from services with ESD [13] . Several factors probably contribute to these differences. First, in our study, only patients whose neurological deficits were non-disabling at discharge, i.e. not interfering with activities of daily living, were included, enabling a direct discharge home without help from a third party. In contrast, the trials on ESD tended to include patients with persisting disability, as shown in the median Barthel index score of 14/20 in a typical patient population. Secondly, our rate of recanalization therapies Composite of any unplanned rehospitalization for any reason within 3 months since hospital discharge and a modified Rankin Score of 3-6 at 3 months. Higher propensity score strata reflect a higher probability of fast-track hospitalization conditional on age, National Institutes of Health Stroke Scale, performance of a recanalization therapy, diabetes and comorbidities (patient clinical complexity level). For example, patients in the strata with the lowest propensity score had 7.64 times higher odds of meeting the primary end-point (3-month modified Rankin Score 3-6 or unplanned rehospitalization) compared to patients in the strata with higher propensity scores. Composite of any unplanned rehospitalization for any reason within 1 month since hospital discharge and a modified Rankin Score of 3-6 at 3 months. was relatively high (16%), which may have improved outcomes at 3 months. In the future, the rate of recanalization is likely to increase, given the advances in endovascular thrombectomy for large-vessel occlusion. Of note, in the intervention arms of the randomized trials on endovascular thrombectomy published over the past 3 years, the proportion of patients able to carry out all usual activities (mRS 0-1) at 3 months was 26.0% [15] , 26.9% [11] and 31% [16] . These rates, along with the high rates of early neurological recovery, may open a window of opportunity for fast-track hospitalizations in selected patients. Thirdly, another source of difference is the shorter follow-up in our study compared to the ESD trials (3 months versus a median of 6 months), with longer follow-ups increasing the odds of an unfavorable outcome. As shown by the PS distribution model, patients with longer hospitalizations were at higher risk of unplanned rehospitalization or poor outcome. This confirms the expected confounding played by age, NIHSS, diabetes, comorbidities and performance of recanalization therapy and underlines the need of a randomized controlled clinical trial comparing fasttrack to long-term hospitalizations to adjust for known and unknown confounders.
In our study, all patients were hospitalized and more than 90% received a complete workup. However, in the fast-track group, slightly more patients had an incomplete workup (+5%). A rapid and complete in-hospital workup can lower the recurrence rate compared to outpatient management, as shown in a cohort study of 8540 patients with minor stroke (NIHSS < 3) or TIA from the Ontario Stroke Registry. In the study from Ontario, the reported rate of 30-day recurrent stroke/TIA was 3.0% amongst hospitalized patients compared to 10.6% amongst patients discharged from the emergency department with referral to an outpatient stroke prevention clinic [17] . Compared to hospitalized patients, patients discharged from a stroke prevention clinic were less likely to receive recommended diagnostic workup and treatments. For instance, amongst hospitalized patients, carotid imaging within 48 h was completed in 55% as opposed to 27% in patients discharged from the emergency department, and anticoagulation in patients with atrial fibrillation was started in 78% as opposed to 68%, respectively [17] . Similarly, a 2018 cohort study from the US Veterans Health Administration showed a quality gap between patients admitted to the hospital and those who were discharged from the emergency department for minor ischaemic stroke or TIA [18] . The greatest disparity in quality was observed for carotid artery imaging by day 2 or within 6 months prior to admission (75.6% amongst admitted patients versus 25.3% amongst patients discharged from the emergency department), followed by antithrombotic use by day 2 (92.7% vs. 53.6%, respectively).
Our observations do not justify hospitalizing all patients with a non-disabling stroke. If patients with a minor stroke or TIA are not hospitalized, outpatient examination and management by a neurologist within 24 h have been proven to reduce the risk of recurrent stroke [19, 20] . Compared to long-term hospitalizations, the reduction in cumulative costs of the 79 fast-track hospitalizations averaged $394 526 (=79 9 $4994 difference in median costs) over 2 years and in just a single center. On a national level, fast-track hospitalizations might contain healthcare expenditures, a main challenge in the USA and also Switzerland, without jeopardizing the quality of health.
Our study has strengths and limitations. Strengths are the inclusion of AIS patients diagnosed on the basis of MR diffusion-weighted imaging. The study took place in a stroke center capable of providing modern endovascular treatments, which will probably increase in the near future. Limitations include a low end-point rate in the overall cohort, which reduces statistical power to detect smaller, but clinically relevant, differences. Despite two different methods to adjust for known and potential confounders, residual confounding remains possible given the cohort study design with non-randomized allocation to the study arms. Only a randomized clinical trial comparing fast-track to longterm hospitalizations can fully adjust for known and unknown confounders. Finally, whilst all patients were assessed at least once by a physiotherapist, a speech therapist and an occupational therapist, the total number of sessions per patient is not available.
Amongst patients with AIS with non-disabling deficits, fast-track hospitalizations including a full workup may be feasible, showed no increased risk, and were less expensive compared to late-discharge hospitalizations. Randomized clinical trials on the safety and efficacy of fast-track hospitalizations appear justified.
